During a biodiversity survey of undiscovered taxa in Korea, two zygomycetous fungal strains were isolated. The first strain, EML-FSDY6-1 was isolated from a soil sample collected at Dokdo Island in the East Sea of Korea in 2013, and the second strain, EML-DG-NH3-1 was isolated from a rat dung sample collected at Chonnam National University garden, Gwangju, Korea in 2014. Based on the morphological characteristics and phylogenetic analysis of the internal transcribed spacer, 18S and 28S rDNA, actin and translation elongation factor-1α genes. EML-FSDY6-1 and EML-DG-NH3-1 isolates were confirmed as zygomycete species, Absidia pseudocylindrospora and Absidia glauca, respectively. Neither species has previously been described in Korea.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838589 | PMC |
| http://dx.doi.org/10.5941/MYCO.2016.44.1.29 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular architecture of chitin and chitosan-dominated cell walls in zygomycetous fungal pathogens by solid-state NMR.
Nat Commun
September 2024
Department of Chemistry, Michigan State University, East Lansing, MI, USA.
Article Synopsis
- Zygomycetous fungal infections are becoming a serious problem for people with weak immune systems.
- Scientists studied the cell walls of some fungi to understand how they grow and how our bodies respond to them.
- They found important details about the cell walls and think that learning more could help create new medicines to fight these fungal infections.
Invasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugs.
Drugs Context
June 2024
Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Background: Invasive fungal infections (IFIs) are important infectious complications amongst critically ill children. The most common fungal infections are due to species. , and are also emerging because of the empirical use of antifungal drugs.
View Article and Find Full Text PDFThe changing trend of fungal infection in invasive rhinosinusitis in the COVID era.
J Family Med Prim Care
April 2024
Department of Microbiology, ABVIMS and RML Hospital, New Delhi, India.
Background: SARS-COV virus operates as a significant risk factor for invasive fungal aspergillosis and mucormycosis. Successful management of this fulminant infection requires early recognition of the disease and aggressive medical or surgical interventions to prevent the high morbidity and mortality associated with the disease process.
Aims And Objective Of The Study: 1.
Facial and systemic mucormycosis caused by in a goat: case report and literature review of fungal infections in goats.
J Vet Diagn Invest
May 2024
Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California-Davis, Davis, CA, USA.
An 8-y-old Pygora doe was presented to the University of California-Davis, Veterinary Medical Teaching Hospital because of non-healing facial swelling of 2-wk duration. The lesion grew despite medical treatment, causing discomfort masticating, little-to-no airflow from the right nasal passage, and led to euthanasia. On gross examination, a large facial mass with a draining tract through the skin and hard palate was identified.
View Article and Find Full Text PDFAn Uncommon Case of Upper-Extremity Mucormycosis in a Patient With Acute Myeloid Leukemia.
J Hand Surg Glob Online
January 2024
Department of Hand and Upper Extremity Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
Upper-extremity mucormycosis is a rare, life-threatening fungal infection mainly affecting immunocompromised patients. We report a case of a 30-year-old woman with acute myelogenous leukemia who developed this infection during her hospital stay. The culprit was Mucorales, a subgroup of Zygomycetes species known for fast-progressing, highly lethal infections.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!